The American Academy of Pediatrics warns current policymakers at the CDC have a history of spreading misinformation.

Since 1964, the US Centers for Disease Control and Prevention (CDC) had regularly reviewed the evidence on the safety and ...

The American Academy of Pediatrics released its updated recommendations for vaccines on Tuesday, including Covid-19 shots for ...

The American Academy of Pediatrics is splitting from the federal government in its recommendations on which children should ...

Beyfortus (nirsevimab) is the only option that can offer RSV protection designed for all infants with proven high, sustained efficacy, favourable safety and public health impact demonstrated in the ...

The test is now authorized for use with anterior nasal swab samples in addition to the previously authorized throat and nasopharyngeal samples.

SHELTON, CONNECTICUT / / August 18, 2025 / NanoViricides, Inc., a publicly traded company (NYSE American:NNVC) (the "Company"), and a clinical stage, leading global pioneer in the development ...

Palivizumab injection (Synagis), an RSV prevention therapy for children, is being discontinued and will no longer be available as of December 31, 2025.

“We’ve stepped back into the world that we lived in before the [CDC’s vaccine advisory committee] was created,” said Dr.

The Food and Drug Administration is considering pulling its authorization of Pfizer’s COVID-19 vaccine for healthy children ...

Research and Development Expenses-- $4,700,000 compared to $5,600,000 during the prior year comparable period. Kodiak PCR ...

Diagnostics' progress on their PCR platform, with key trials in 2025 and commercialization plans by 2026, targeting U.S. and global markets.